- Home
- ENVB vs WHLR Comparison
ENVB vs WHLR Comparison
Compare ENVB & WHLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- WHLR
- Stock Information
- Founded
- ENVB 1994
- WHLR 2011
- Country
- ENVB United States
- WHLR United States
- Employees
- ENVB N/A
- WHLR N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- WHLR Real Estate Investment Trusts
- Sector
- ENVB Health Care
- WHLR Real Estate
- Exchange
- ENVB Nasdaq
- WHLR Nasdaq
- Market Cap
- ENVB 2.7M
- WHLR 2.9M
- IPO Year
- ENVB N/A
- WHLR 2012
- Fundamental
- Price
- ENVB $1.19
- WHLR $1.77
- Analyst Decision
- ENVB Strong Buy
- WHLR
- Analyst Count
- ENVB 1
- WHLR 0
- Target Price
- ENVB $10.00
- WHLR N/A
- AVG Volume (30 Days)
- ENVB 81.9K
- WHLR 418.1K
- Earning Date
- ENVB 08-14-2025
- WHLR 08-05-2025
- Dividend Yield
- ENVB N/A
- WHLR N/A
- EPS Growth
- ENVB N/A
- WHLR N/A
- EPS
- ENVB N/A
- WHLR N/A
- Revenue
- ENVB N/A
- WHLR $102,799,000.00
- Revenue This Year
- ENVB N/A
- WHLR N/A
- Revenue Next Year
- ENVB N/A
- WHLR N/A
- P/E Ratio
- ENVB N/A
- WHLR N/A
- Revenue Growth
- ENVB N/A
- WHLR N/A
- 52 Week Low
- ENVB $1.01
- WHLR $1.75
- 52 Week High
- ENVB $8.69
- WHLR $10,458.00
- Technical
- Relative Strength Index (RSI)
- ENVB 50.71
- WHLR 21.60
- Support Level
- ENVB $1.10
- WHLR $1.94
- Resistance Level
- ENVB $1.20
- WHLR $2.49
- Average True Range (ATR)
- ENVB 0.07
- WHLR 0.33
- MACD
- ENVB 0.01
- WHLR -0.00
- Stochastic Oscillator
- ENVB 82.35
- WHLR 1.33
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.